Addex Therapeutics (ADXN) Interest Expenses (2022 - 2025)
Historic Interest Expenses for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$1021.3.
- Addex Therapeutics' Interest Expenses rose 9258.1% to -$1021.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $4066.3, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $4031.9 for FY2024, which is 9887.25% down from last year.
- Latest data reveals that Addex Therapeutics reported Interest Expenses of -$1021.3 as of Q3 2025, which was up 9258.1% from $7039.6 recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Interest Expenses peaked at $443297.6 during Q4 2022, and registered a low of -$12.9 billion during Q4 2023.
- Its 4-year average for Interest Expenses is -$859.6 million, with a median of -$1021.3 in 2025.
- Per our database at Business Quant, Addex Therapeutics' Interest Expenses crashed by 290882763.44% in 2023 and then surged by 83681.63% in 2025.
- Addex Therapeutics' Interest Expenses (Quarter) stood at $443297.6 in 2022, then tumbled by 2908827.63% to -$12.9 billion in 2023, then surged by 100.0% to $19347.7 in 2024, then plummeted by 105.28% to -$1021.3 in 2025.
- Its Interest Expenses was -$1021.3 in Q3 2025, compared to $7039.6 in Q2 2025 and -$21299.6 in Q1 2025.